Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine-neostigmine versus ondansetron for prevention of post-spinal headache after cesarean section
IRCT20160307026950N39Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in post-dural puncture headache (PDPH) comparing Atropine + neostigmine, Ondansetron and Placebo distilled water (3 arms). Primary endpoint: Headache after spinal anesthesia. Started Jan 2022; status: completed.
02
Drugs
atropineneostigmineondansetron
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20160307026950N39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N39.